Transactions
St. Louis Clinical Trials recapitalized by DFW Capital Partners
Apr. 2014
Client: SLCT is a leading clinical pharmacology and research services company focusing on psychiatric indications
Role: Edgemont Partners acted as exclusive financial advisor to St. Louis Clinical Trials in its recapitalization and merger to form Evolution Research Group sponsored by DFW Capital
Location: St. Louis, MO
Sector: Pharmaceutical Services
Lead Banker: David Blume
![st. louis clinical trials logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/6-Top.png)
recapitalized by
![dfw capital partners logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/4-Bottom.jpg)